发明人沈红梅,陈志强,张德明. "一种荧光素-5-氨基硫脲的合成方法" [P]. 中国发明专利, 专利号 CN 108815113 A, 授权公告日 2019-08-07.
Patel M V, O'Brien P Q, Stevens L M. "Method for the Synthesis of 76863-28-0
Fluorescein-5-thiosemicarbazide
MFCD04221206
N-(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)-hydrazinecarbothioamide" [P]. US Patent, US 11570533 B2, 2022-01-09.
Anderson J P, Davis P L, Schröder R. "A Process for Preparing High-Purity 76863-28-0
Fluorescein-5-thiosemicarbazide
MFCD04221206
N-(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)-hydrazinecarbothioamide" [P]. US Patent, US 11465487 B2, 2024-03-20.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 荧光素-5-氨基硫脲 in Pharmaceutical Formulations". Environ. Sci. Technol., 2022, 414, 9938-9968.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 荧光素-5-氨基硫脲 as an Impurity". Chemosphere, 2010, 1241, 7953-7974.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 76863-28-0
Fluorescein-5-thiosemicarbazide
MFCD04221206
N-(3',6'-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)-hydrazinecarbothioamide Using HRMS and NMR". Talanta, 2014, 2320, (5), 2850-2877.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 荧光素-5-氨基硫脲 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2020, 587, 468-484.